Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4866868
Max Phase: Preclinical
Molecular Formula: C19H25N3O8
Molecular Weight: 423.42
Molecule Type: Unknown
Associated Items:
ID: ALA4866868
Max Phase: Preclinical
Molecular Formula: C19H25N3O8
Molecular Weight: 423.42
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C(O)CCCCOc1ccc(-c2cn([C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O)nn2)cc1
Standard InChI: InChI=1S/C19H25N3O8/c23-10-14-16(26)17(27)18(28)19(30-14)22-9-13(20-21-22)11-4-6-12(7-5-11)29-8-2-1-3-15(24)25/h4-7,9,14,16-19,23,26-28H,1-3,8,10H2,(H,24,25)/t14-,16-,17+,18+,19+/m1/s1
Standard InChI Key: LCKAAHOOHDNXEQ-IQRFUGTFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 423.42 | Molecular Weight (Monoisotopic): 423.1642 | AlogP: -0.45 | #Rotatable Bonds: 9 |
Polar Surface Area: 167.39 | Molecular Species: ACID | HBA: 10 | HBD: 5 |
#RO5 Violations: 0 | HBA (Lipinski): 11 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 4.30 | CX Basic pKa: | CX LogP: -0.07 | CX LogD: -3.04 |
Aromatic Rings: 2 | Heavy Atoms: 30 | QED Weighted: 0.33 | Np Likeness Score: 0.18 |
1. Tomašič T, Rabbani S, Jakob RP, Reisner A, Jakopin Ž, Maier T, Ernst B, Anderluh M.. (2021) Does targeting Arg98 of FimH lead to high affinity antagonists?, 211 [PMID:33340913] [10.1016/j.ejmech.2020.113093] |
Source(1):